This article is more than 5 years old. Information may no longer be current.
Mobius Therapeutics voluntarily recalls two lots of Mitosol
Click Here to Manage Email Alerts
Mobius Therapeutics is voluntarily recalling two lots of Mitosol because they may be non-sterile, according to a company news release.
Mitosol (mitomycin for solution) is an antimetabolite used as an adjunct to ab externo glaucoma surgery. The kits in the lots may contain a strain of yeast on one or more parts in the kit and should be considered non-sterile and unsafe for use, the release said.
Use of the kits could result in serious eye problems and infections, although no reports of such problems have been made.
The lots being recalled are M098260 and M086920 with an expiration date of August 2013. The lots were distributed in Alabama, Arkansas, Delaware, Georgia, Illinois, Indiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Virginia and Wisconsin between Oct. 22, 2012, and Dec. 14, 2012.
Call Mobius at 1-877-393-6486, option 2, for details on how to return the product.